Cargando…

Meeting Report: Harmonization of RSV therapeutics – from design to performance

Detalles Bibliográficos
Autores principales:	Nair, Harish, Ramilo, Octavio, Eichler, Irmgard, Pelfrene, Eric, Mejias, Asuncion, Polack, Fernando P, Pouwels, Koen B., Langley, Joanne M., Nunes, Marta, van der Maas, Nicoline, Kragten–Tabatabaie, Leyla, Baraldi, Eugenio, Heikkinen, Terho, Fauroux, Brigitte, Sharland, Mike, Park, Cyrus, Manzoni, Paolo, Papadopoulos, Nikolaos G., Martinón–Torres, Federico, Stein, Renato, Bont, Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Edinburgh University Global Health Society 2016
Materias:	News: Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920015/ http://dx.doi.org/10.7189/jogh.06.010205

Ejemplares similares

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures
por: Billard, Marie‐Noëlle, et al.
Publicado: (2022)

2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection
por: Bedoya, Santiago Acero, et al.
Publicado: (2019)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development
por: Taveras, Jeanette, et al.
Publicado: (2019)

Respiratory Syncytial Virus (RSV)–Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants
por: Koivisto, Karoliina, et al.
Publicado: (2021)

1186. Increased Respiratory Syncytial Virus (RSV) Viral Replication Leads to Increased Cytokine Production and Polarized Interferon Response in Infant Mucosal Epithelium
por: Glowinski, Rebecca M, et al.
Publicado: (2021)

Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse Model
por: Mejías, Asunción, et al.
Publicado: (2007)

131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection
por: Taveras, Jeanette, et al.
Publicado: (2020)

2352. Increased on Childhood Recurrent Wheezing and Asthma After Respiratory Syncytial Viral (RSV) Infection in Full-Term Infants
por: Mejias, Asuncion, et al.
Publicado: (2018)

Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017−2018 INFORM-RSV Study
por: Tabor, David E., et al.
Publicado: (2020)

118. Nasopharyngeal (NP) Bacterial Detection in Infants With Respiratory Syncytial Virus (RSV) Infection: Impact on Clinical Outcomes
por: Diaz, Alejandro, et al.
Publicado: (2018)

1465. Age-Dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children with Respiratory Syncytial Virus Infection (RSV) Infection
por: Brenes-Chacon, Helena, et al.
Publicado: (2020)

Respiratory Syncytial Virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice
por: Torres, Juan Pablo, et al.
Publicado: (2010)

RSV: perspectives to strengthen the need for protection in all infants
por: Navarro Alonso, Jose Antonio, et al.
Publicado: (2021)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
por: Gastaldi, Andrea, et al.
Publicado: (2021)

The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines
por: King, Tiffany, et al.
Publicado: (2021)

RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
por: Esposito, Susanna, et al.
Publicado: (2022)

The importance of viral testing in infants and young children with bronchiolitis()
por: Mejias, Asuncion, et al.
Publicado: (2022)

1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005
por: Martinon-Torres, Federico, et al.
Publicado: (2018)

The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: A systematic review and meta–analysis
por: Chan, Markus, et al.
Publicado: (2017)

Pharmacokinetics, Safety, and Antiviral Effects of Multiple Doses of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678, in Infants Hospitalized With RSV Infection: A Randomized Phase 1b Study
por: Martinón-Torres, Federico, et al.
Publicado: (2020)

Superiority of Transcriptional Profiling Over Procalcitonin for Distinguishing Bacterial From Viral Lower Respiratory Tract Infections in Hospitalized Adults
por: Suarez, Nicolas M., et al.
Publicado: (2015)

Respiratory Syncytial Virus bronchiolitis: Impact of second-hand smoke exposure on immune profiles
por: Diaz, Alejandro, et al.
Publicado: (2017)

118 Transcriptional Profiling Discriminates Complete and Incomplete Kawasaki Disease (KD) from Adenovirus infection (HAdV)
por: Jaggi, Preeti, et al.
Publicado: (2014)

Viral Loads and Disease Severity in Children with Rhinovirus-Associated Illnesses
por: Sanchez-Codez, Maria I., et al.
Publicado: (2021)

Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection
por: Garcia-Mauriño, Cristina, et al.
Publicado: (2019)

The long road to protect infants against severe RSV lower respiratory tract illness
por: Jares Baglivo, Sofia, et al.
Publicado: (2019)

Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia
por: Wallihan, Rebecca G., et al.
Publicado: (2018)

Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant
por: Quintero, Ana Maria, et al.
Publicado: (2022)

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
por: Scheltema, Nienke M, et al.
Publicado: (2017)

TLR4 Gene Polymorphisms Interaction With Ascaris Infection in Severe RSV Bronchiolitis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
por: Nederend, Maaike, et al.
Publicado: (2020)

Respiratory syncytial virus (RSV) disease – new data needed to guide future policy
por: Campbell, Harry, et al.
Publicado: (2015)

Quantifying the RSV immunity debt following COVID-19: a public health matter
por: Billard, Marie-Noëlle, et al.
Publicado: (2022)

Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union
por: van Beek, Dianne, et al.
Publicado: (2013)

Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: An experimental murine model
por: Chávez-Bueno, Susana, et al.
Publicado: (2005)

Prevalence, Genotypes, Clinical Manifestations and Outcomes Associated with Human Parechovirus (HPeV) Infections in Infants up to 2 Months old in Central Ohio
por: Souverbielle, Cristina Tomatis, et al.
Publicado: (2017)

A Systems Analysis Approach to Define the Protective Host Immune Responses of Children with Mild Respiratory Syncytial Virus Infection
por: Heinonen, Santtu, et al.
Publicado: (2017)

79. Children with COVID-19 Demonstrate Distinct Serum Cytokines Profiles According to Clinical Presentations
por: Xu, Zhaohui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_us4h4s77i6ahbq6b410nr64ih3